Attributable cost of methicillin resistance: an issue that is difficult to evaluate.
Estimating the consequences and the cost of methicillin resistance is a difficult challenge. Patients who develop methicillin-resistant ventilator-associated pneumonia (VAP) are very different from those who develop methicillin-sensitive VAP, and biased estimates are frequent. We reviewed some important confounding factors of which the reader should be aware.
Timsit
Jean-François
JF
Groupe d'Epidémiologie des Cancers et des Affections Graves INSERM U 578, Service de Réanimation Médicale, University Hospital Albert Michallon, 38043 Grenoble Cedex, France. jftimsit@chu-grenoble.fr
D003365:Costs and Cost Analysis; D006801:Humans; D016106:Methicillin Resistance; D011023:Pneumonia, Staphylococcal / Q000191:economics* / Q000209:etiology; D012121:Respiration, Artificial / Q000009:adverse effects* / Q000191:economics*